Makowka will manage relationships with AHA Ventures portfolio companies.

GCV has looked through our data to find the busiest investors in corporate venture capital. Here's how and where they invested in 2024.

AI funding rounds commanded huge prices in 2024, but corporate investors also made large bets in healthcare, energy and robotics.

King worked at Intel's corporate venturing arm before joining the investment arm of the newly listed healthcare company.

There was a 62% jump in exits for corporate-backed startups in November, with IPOs and acquisitions across a range of geographies and sectors but also some notable bankruptcies.

Telemedicine didn't solve the fundamental cost problem in healthcare, but new AI models may be tackling this.

Some 37 corporate-backed startups were either acquired or taken public in October, with the total value of exits at $4.37bn, a significant rise on last year.

The US cardiovascular health research and public awareness nonprofit has launched a fund for startups tackling women's health conditions.

With shortages in labour and resources in the US healthcare system, medium-sized funds have a unique role to play to bridge the gaps.

Personalised treatment, combination therapies, vaccines and of course AI: pharmaceutical investors are backing a surge of new cancer technologies.